Tadmor T - Search Results

1

The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model.

Tadmor T, Zhang Y, Cho HM, Podack ER, Rosenblatt JD. Tadmor T, et al. Cancer Immunol Immunother. 2011 May;60(5):609-19. doi: 10.1007/s00262-011-0972-z. Epub 2011 Jan 21. Cancer Immunol Immunother. 2011. PMID: 21253724 Free PMC article.

2

Inhibition of antitumor immunity by B cells.

Rosenblatt J, Zhang YD, Tadmor T. Rosenblatt J, et al. Among authors: tadmor t. Cancer Res. 2007 May 15;67(10):5058-9; author reply 5059. doi: 10.1158/0008-5472.CAN-06-3903. Cancer Res. 2007. PMID: 17510442 No abstract available.

3

CD30: an important new target in hematologic malignancies.

Deutsch YE, Tadmor T, Podack ER, Rosenblatt JD. Deutsch YE, et al. Among authors: tadmor t. Leuk Lymphoma. 2011 Sep;52(9):1641-54. doi: 10.3109/10428194.2011.574761. Epub 2011 May 27. Leuk Lymphoma. 2011. PMID: 21619423 Review.

4

B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion.

Zhang Y, Eliav Y, Shin SU, Schreiber TH, Podack ER, Tadmor T, Rosenblatt JD. Zhang Y, et al. Among authors: tadmor t. Cancer Immunol Immunother. 2013 Jan;62(1):87-99. doi: 10.1007/s00262-012-1313-6. Epub 2012 Jul 8. Cancer Immunol Immunother. 2013. PMID: 22772949 Free PMC article.

5

Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy.

Tadmor T, Attias D, Polliack A. Tadmor T, et al. Br J Haematol. 2011 Jun;153(5):557-67. doi: 10.1111/j.1365-2141.2011.08678.x. Epub 2011 Apr 8. Br J Haematol. 2011. PMID: 21477210 Free article. Review.

6

Significance of bone marrow reticulin fibrosis in chronic lymphocytic leukemia at diagnosis: a study of 176 patients with prognostic implications.

Tadmor T, Shvidel L, Aviv A, Ruchlemer R, Bairey O, Yuklea M, Herishanu Y, Braester A, Rahimi-Levene N, Vernea F, Ben-Ezra J, Bejar J, Polliack A; Israeli CLL Study Group. Tadmor T, et al. Cancer. 2013 May 15;119(10):1853-9. doi: 10.1002/cncr.27930. Epub 2013 Feb 19. Cancer. 2013. PMID: 23423815 Free article.

7

Do lymphocytes count in myeloma? Are we absolutely sure?

Tadmor T. Tadmor T. Leuk Lymphoma. 2015 May;56(5):1193-4. doi: 10.3109/10428194.2014.1001989. Epub 2015 Feb 20. Leuk Lymphoma. 2015. PMID: 25563426 No abstract available.

8

Characteristics of primary splenic diffuse large B-cell lymphoma and role of splenectomy in improving survival.

Bairey O, Shvidel L, Perry C, Dann EJ, Ruchlemer R, Tadmor T, Goldschmidt N. Bairey O, et al. Among authors: tadmor t. Cancer. 2015 Sep 1;121(17):2909-16. doi: 10.1002/cncr.29487. Epub 2015 Jun 19. Cancer. 2015. PMID: 26096161 Free article.

9

Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia.

Michelis R, Milhem L, Galouk E, Stemer G, Aviv A, Tadmor T, Shehadeh M, Shvidel L, Barhoum M, Braester A. Michelis R, et al. Among authors: tadmor t. Front Immunol. 2022 Sep 2;13:953644. doi: 10.3389/fimmu.2022.953644. eCollection 2022. Front Immunol. 2022. PMID: 36119042 Free PMC article.

10

Alemtuzumab (Campath-1H) for chronic lymphocytic leukemia: a drug in search of its optimal schedule.

Tadmor T. Tadmor T. Leuk Lymphoma. 2011 Oct;52(10):1831-3. doi: 10.3109/10428194.2011.585531. Epub 2011 May 23. Leuk Lymphoma. 2011. PMID: 21599582 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters